The most recent conference call was with Dr Robin Lachmann of the Charles Dent Metabolic Unit in London. Dr Lachmann has a few years background in seeing TMAU patients.
A podcast of the conference call can be heard on the BORC podcast website
Dr Robin Lachmann conference call with BORC
BORC youtube channel : link
My view on TMAU
Personally I think people with a problem with their FMO3 enzyme may be prone to smelling of various sulfides and amines that are oxidized by FMO3. This would include trimethylamine but it may be a 'small player' in the number of compounds the person smells of. TMAU came about because the professionals at the time were only looking for trimethylamine. There has been no attempts to look for other compounds. However TMAU is a useful lever to rasie awareness of the concept of metabolic malodors, and trimethylamine should also be a good biomarker of FMO3 function which I suspect is the main enzyme responsible for most cases of metabolic malodor.
0 comments:
Post a Comment